Ibrutinib - CAS# 936563-96-1 Catalog No.:M10967-2 Glut1 deficiency syndrome and erythrocyte

Glut1 deficiency syndrome and erythrocyte glucose uptake assay

is a novel and selective voltage-gated sodium channel for pain treatment

Smiles: C[C@@H]1O[C@H](C[C@H](N)[C@@H]1O)O[C@H]1C[C@@](O)(CC2=C1C(O)=C1C(=O)C3=C(C=CC=C3C(=O)C1=C2O)OC)C(=O)CO

pii: E1086

3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanamido]ethoxy}ethoxy)ethoxy]acetate

Ibrutinib - CAS# 936563-96-1 Catalog No.:M10967-2 Glut1 deficiency syndrome and erythrocyteIbrutinib, also known as PCI 32765, is a potent and orally active BTK inhibitor. Ibrutinib binds to and inhibits BTK activity, preventing B cell activation and B cell mediated signaling and inhibiting the growth of malignant B cells that overexpress BTK. Ibrutinib was approved by the US FDA on November 13, 2013 for the treatment of mantle cell lymphoma. Product information CAS Number: 936563 96 1 Molecular Weight: 440. 50 Formula: C25H24N6O2 Synonym: